Tarsons Products Limited

BSE:543399 Stock Report

Market Cap: ₹20.8b

Tarsons Products Valuation

Is 543399 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 543399 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 543399 (₹389.9) is trading above our estimate of fair value (₹166.85)

Significantly Below Fair Value: 543399 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 543399?

Key metric: As 543399 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 543399. This is calculated by dividing 543399's market cap by their current earnings.
What is 543399's PE Ratio?
PE Ratio60.1x
Earnings₹345.49m
Market Cap₹20.77b

Price to Earnings Ratio vs Peers

How does 543399's PE Ratio compare to its peers?

The above table shows the PE ratio for 543399 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average45.5x
524394 Vimta Labs
44.6xn/a₹22.0b
WINDLAS Windlas Biotech
35.8xn/a₹21.9b
544184 Borosil Scientific
50.6xn/a₹14.6b
INNOVACAP Innova Captab
51.1x29.7%₹60.4b
543399 Tarsons Products
60.1x27.7%₹20.8b

Price-To-Earnings vs Peers: 543399 is expensive based on its Price-To-Earnings Ratio (60.1x) compared to the peer average (45.5x).

Price to Earnings Ratio vs Industry

How does 543399's PE Ratio compare vs other companies in the Asian Life Sciences Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
543399 60.1xIndustry Avg. 33.8xNo. of Companies6PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 543399 is expensive based on its Price-To-Earnings Ratio (60.1x) compared to the Asian Life Sciences industry average (33.8x).

Price to Earnings Ratio vs Fair Ratio

What is 543399's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

543399 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio60.1x
Fair PE Ratio35.4x

Price-To-Earnings vs Fair Ratio: 543399 is expensive based on its Price-To-Earnings Ratio (60.1x) compared to the estimated Fair Price-To-Earnings Ratio (35.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 543399 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹389.90
₹597.75
+53.3%
22.2%₹760.00₹430.00n/a4
Dec ’25₹419.55
₹597.75
+42.5%
22.2%₹760.00₹430.00n/a4
Nov ’25₹407.75
₹551.25
+35.2%
26.1%₹700.00₹407.00n/a4
Oct ’25₹447.70
₹551.25
+23.1%
26.1%₹700.00₹407.00n/a4
Sep ’25₹451.55
₹551.25
+22.1%
26.1%₹700.00₹407.00n/a4
Aug ’25₹507.60
₹570.50
+12.4%
25.6%₹740.00₹407.00n/a4
Jul ’25₹508.65
₹566.75
+11.4%
25.0%₹725.00₹407.00n/a4
Jun ’25₹413.55
₹649.00
+56.9%
14.6%₹770.00₹511.00n/a4
May ’25₹459.30
₹649.00
+41.3%
14.6%₹770.00₹511.00n/a4
Apr ’25₹426.55
₹644.00
+51.0%
13.8%₹750.00₹511.00n/a4
Mar ’25₹468.50
₹644.00
+37.5%
13.8%₹750.00₹511.00n/a4
Feb ’25₹492.60
₹647.00
+31.3%
15.9%₹760.00₹511.00n/a3
Jan ’25₹527.90
₹644.25
+22.0%
13.9%₹760.00₹511.00n/a4
Dec ’24₹471.85
₹637.40
+35.1%
13.3%₹760.00₹511.00₹419.555
Nov ’24₹467.50
₹661.60
+41.5%
9.9%₹775.00₹590.00₹407.755
Oct ’24₹526.00
₹671.40
+27.6%
9.2%₹775.00₹590.00₹447.705
Sep ’24₹527.40
₹691.75
+31.2%
7.5%₹775.00₹636.00₹451.554
Aug ’24₹610.35
₹716.75
+17.4%
13.0%₹875.00₹636.00₹507.604
Jul ’24₹603.25
₹710.50
+17.8%
11.7%₹850.00₹636.00₹508.654
Jun ’24₹571.20
₹740.25
+29.6%
9.6%₹850.00₹666.00₹413.554
May ’24₹565.05
₹786.75
+39.2%
8.6%₹900.00₹722.00₹459.304
Apr ’24₹532.75
₹786.75
+47.7%
8.6%₹900.00₹722.00₹426.554
Mar ’24₹591.15
₹808.33
+36.7%
8.1%₹900.00₹755.00₹468.503
Feb ’24₹687.20
₹841.67
+22.5%
13.3%₹1,000.00₹755.00₹492.603
Jan ’24₹693.20
₹851.67
+22.9%
14.8%₹1,030.00₹755.00₹527.903
Dec ’23₹703.45
₹851.67
+21.1%
14.8%₹1,030.00₹755.00₹471.853

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 18:27
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tarsons Products Limited is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nitin BhasinAmbit Capital
Karan KhannaAmbit Capital
Vijayaraghavan SwaminathanAvendus Spark